Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.



Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

Order results by:     
Issue Title
Vol 19, No 2 (2016) The associations of incretin hormone concentration with gestational diabetes mellitus
Abstract PDF
(Rus)
similar documents
Saprina T.V., Timokhina E.S., Goncharevich O.K., Budeeva S.V., Prokhorenko T.S., Tashireva L.A., Musina N.N., Dronova I.V.
"... of enteroinsulin hormones [glucagon, glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide1 (GLP-1 ..."
Vol 14, No 3 (2011) Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
Abstract PDF
(Rus)
similar documents
Ametov A.S., Kamynina L.L.
Vol 14, No 3 (2011) New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
Abstract PDF
(Rus)
similar documents
Shestakova E.A.
Vol 20, No 4 (2017) Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
Abstract PDF
(Rus)
similar documents
Galstyan G.R., Karataeva E.A., Yudovich E.A.
"... Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) are a class of antidiabetic drugs ..."
Vol 22, No 1 (2019) Incretins today: multiple effects and therapeutic potential
Abstract PDF
(Rus)
PDF
(Rus)
similar documents
Tsygankova O.V., Veretyuk V.V., Ametov A.S.
"... Glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1 ..."
Vol 13, No 3 (2010) The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
Abstract PDF
(Rus)
similar documents
Shestakova M.V.
"... The first human glucagon-like peptide-1 analog (liraglutide) was registered in Russia in May 2010 ..."
Vol 21, No 4 (2018) Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
Abstract PDF
(Rus)
similar documents
Petunina N.A., Telnova M.Е.
"... with a lower secretion of glucagon-like peptide-1. The interest is represented by groups of antidiabetic drugs ..."
Vol 16, No 3 (2013) Glucagon and alpha-cells as a novel therapeutic target in the management of diabetes mellitus
Abstract PDF
(Rus)
similar documents
Petunina N.A., Trukhina L.V., Sinicyna E.I., Shestakova M.V.
"... For the past several years, a number of studies addressed glucagon and its role in glycemic ..."
Vol 14, No 2 (2011) Sakharnyy diabet i gormonal'naya enterologiya: put' v prekrasnoe daleko?
Abstract PDF
(Rus)
similar documents
Aleksandrov A.A.
"... secretion. One of them is glucagon-like peptide 1.Its synthetic analog, liraglutide, has properties ..."
Vol 14, No 2 (2011) Dipeptidylpeptidase-4 inhibitors in the treatment of diabetes mellitus. Possibilities of cardioprotection
Abstract PDF
(Rus)
similar documents
Trunina E.N., Petunina N.A., Chorbinskaya S.A.
Vol 19, No 1 (2016) Mechanisms of neuroprotective action of incretin mimetics
Abstract PDF
(Rus)
similar documents
Vlasov T.D., Simanenkova A.V., Dora S.V., Shlyakhto E.V.
"... Recently, on the pharmacological market, new drugs from the class of incretin mimetics, or glucagon ..."
Vol 18, No 4 (2015) Vildagliptin: optimal control in type 2 diabetes mellitus treatment
Abstract PDF
(Rus)
similar documents
Ametov A.S.
"... ), leading to impaired insulin secretion, insulin resistance due to elevated glucagon levels ..."
Vol 19, No 1 (2016) Incretin-based therapy: renal effects
Abstract PDF
(Rus)
similar documents
Korbut A.I., Klimontov V.V.
"... Glucagon like peptide-1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors are new ..."
Vol 16, No 4 (2013) Immunohystochemical study of the largest islets of human pancreas in aging and diabetes mellitus: perspectives for the transplantation
Abstract PDF
(Rus)
HTML
(Rus)
similar documents
Proshchina A.E., Krivova Y.S., Barabanov V.M., Savelyev S.V.
"... .  Antibodies to insulin, glucagon, somastatin and nturon-specific enolase were applied. The autopsy samples ..."
Vol 20, No 3 (2017) Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies
Abstract PDF
(Rus)
similar documents
Shestakova M.V., Yudovich E.A.
"... . Dulaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist that causes a variety of antidiabetogenic ..."
Vol 21, No 5 (2018) Mechanisms of cardiovascular protection of non-insulin antidiabetic medications
Abstract PDF
(Rus)
PDF
(Eng)
similar documents
Avogaro A.
"... inhibitors (DPP-4-I), also called gliptins, increase the concentration of glucagon-like peptide-1 by 2 to 4 ..."
1 - 16 of 16 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)